v3.25.2
CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($)
$ in Thousands
Jun. 30, 2025
Dec. 31, 2024
Current assets:    
Cash and cash equivalents $ 171,416 $ 188,231
Restricted cash and equivalents 0 5,629
Marketable securities 155,585 211,737
Receivables, net 1,047,164 1,017,040
Prepaid expenses and other current assets, net 78,495 35,137
Total current assets 1,452,660 1,457,774
Property and equipment, net 27,410 28,169
Intangible assets, net 65,595 72,771
Goodwill 24,133 24,133
Other assets 143,097 151,136
Total assets 1,712,895 1,733,983
Current liabilities:    
Medical claims and related payables 1,042,257 931,664
Accounts payable and accrued expenses 171,886 220,342
Current debt 34,945 0
Total current liabilities 1,249,088 1,152,006
Long-term debt 0 34,904
Other liabilities 54,878 76,121
Total liabilities 1,303,966 1,263,031
Commitments and contingencies
Stockholders' equity (deficit):    
Common stock, $0.01 par value: 2,000,000 shares authorized; 414,283 and 412,194 shares issued and outstanding, respectively 4,143 4,122
Additional paid-in capital 2,083,234 2,053,895
Accumulated deficit (1,679,235) (1,586,977)
Accumulated other comprehensive income (loss) 787 (88)
Total stockholders’ equity (deficit) 408,929 470,952
Total liabilities and stockholders’ equity (deficit) $ 1,712,895 $ 1,733,983